Serum Marker Score Based on Prognostic Nutrition Index, Carcinoembryonic Antigen, and Carbohydrate Antigen 19-9 Is Associated With Recurrence for Patients Undergoing Surgery for Pancreatic Ductal Adenocarcinoma

Pancreas
Shigeki NakagawaHideo Baba

Abstract

The prognostic value of the prognostic nutrition index (PNI) in pancreatic ductal adenocarcinoma (PDAC) is still controversial. This study aimed to assess the correlation between PNI and the outcome for PDAC patients and to generate a new score from PNI and serum markers. This study investigated 151 patients who underwent pancreatic resection for PDAC between April 2002 and June 2012. Disease-free survival (DFS), overall survival, and clinicopathological parameters were analyzed according to the PNI value. The low PNI patients had poorer 5-year DFS rate than high-PNI patients (10.7% and 34.8%, respectively). Multivariate analyses revealed that independent risk factors for poor DFS were high carcinoembryonic antigen (hazard ratio [HR], 1.53; P = 0.038), high carbohydrate antigen 19-9 (HR, 1.67; P = 0.017), positive lymph node metastasis (HR, 1.98; P = 0.017), R1 or 2 resection (HR, 3.50; P < 0.001), and low PNI (HR, 0.37 [high/low]; P = 0.029]. Scoring based on the formula -0.49 × (PNI) + 0.41 × (carcinoembryonic antigen) + 0.67 × (carbohydrate antigen 19-9) was significantly associated with poor DFS (P < 0.001) and overall survival (P = 0.0019). Low PNI and serum marker score are significantly associated with poor DFS.

References

Mar 31, 2004·Lancet·Donghui LiJames L Abbruzzese
Nov 13, 2004·European Journal of Clinical Nutrition·M A El-HodhodS M Gomaa
Feb 22, 2008·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Oct 21, 2010·The British Journal of Surgery·M KandaA Nakao
May 31, 2011·Lancet·Audrey VincentMichael Goggins
Mar 13, 2012·World Journal of Surgery·Masayuki WatanabeHideo Baba
Dec 20, 2014·Cancer Biomarkers : Section a of Disease Markers·Oskar FranklinMalin Sund
Oct 30, 2015·British Journal of Biomedical Science·Z WangC Zhao
Dec 23, 2016·OncoTargets and Therapy·Douglas S SwordsSean J Mulvihill
Jun 24, 2017·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·T MacarullaM Hidalgo
Jul 10, 2017·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M ItchinsS Clarke
Aug 9, 2017·Journal of the National Comprehensive Cancer Network : JNCCN·Lingling Du, Andrea Wang-Gillam
Aug 18, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marianne SinnHanno Riess
Aug 26, 2017·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·Thilo HackertMarkus W Büchler

❮ Previous
Next ❯

Citations

Feb 4, 2021·Annals of Gastroenterological Surgery·Keinosuke IshidoTaiichi Wakiya
Aug 25, 2021·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Shinji ItohMasaki Mori

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.